1. Global Forum of Cancer Surgeons: Declaration of Intent

   • Chandrakanth Are
   • Daniel G. Coit
   • Juan Enrique Bargallo-Rocha

   Health Services Research and Global Oncology 05 July 2017 Pages: 2429 - 2431

2. Positive Margins After Resection of Metastatic Colorectal Cancer in the Liver: Back to the Drawing Board?

   • M. I. D’Angelica

   Hepatobiliary Tumors 31 May 2017 Pages: 2432 - 2433

3. Bilateral Prophylactic Mastectomy and Immediate Breast Reconstruction in High-Risk Women: The Importance of Health-Related Quality of Life in Decision Making

   • Valerie Lemaine

   Breast Oncology 09 June 2017 Pages: 2434 - 2435

4. Clinical Outcomes in pT4 Tongue Carcinoma are Worse Than in pT3 Disease: How Extrinsic Muscle Invasion Should be Considered?

   • Carol M. Lewis

   Head and Neck Oncology 22 June 2017 Pages: 2436 - 2437

5. The Prognostic Impact of Determining Resection Margin Status for Multiple Colorectal Metastases According to the Margin of the Largest Lesion

   • Kazunari Sasaki
   • Georgios A. Margonis
   • Timothy M. Pawlik

   Hepatobiliary Tumors 10 July 2017 Pages: 2438 - 2446

   

6. LiMAx Test Improves Diagnosis of Chemotherapy-Associated Liver Injury Before Resection of Colorectal Liver Metastases

   • Johan F. Lock
   • Tilman Westphal
   • Martin Stockmann

   Hepatobiliary Tumors 17 May 2017 Pages: 2447 - 2455

   

7. Immaturity of Bile Canalicular–Ductule Networks in the Future Liver Remnant While Associating Liver Partition and Portal Vein Occlusion for Staged Hepatectomy (ALPPS)

   • Kenichi Matsuo
   • Yukihiko Hiroshima
   • Kuniya Tanaka

   Hepatobiliary Tumors 13 June 2017 Pages: 2456 - 2464

   

8. The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres

   • Fernando Pardo
   • Bruno Sangro
   • Michael Schoen

   Hepatobiliary Tumors 26 June 2017 Pages: 2465 - 2473

9. Relevance of Dissection of the Posterior Superior Pancreaticoduodenal Lymph Nodes in Gallbladder Carcinoma

   • Jun Sakata
   • Takashi Kobayashi
   • Toshifumi Wakai

   Hepatobiliary Tumors 26 June 2017 Pages: 2474 - 2481

   

10. Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer

    • Amber L. Simpson
    • Alexandre Doussot
    • Michael I. D’Angelica

    Colorectal Cancer 30 May 2017 Pages: 2482 - 2490

    

11. Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma

    • Fabio Bagante
    • Gaya Spolverato
    • Timothy M. Pawlik

    Gastrointestinal Oncology 02 May 2017 Pages: 2491 - 2501

    

12. Impact of Bilateral Prophylactic Mastectomy and Immediate Reconstruction on Health-Related Quality of Life in Women at High Risk for Breast Carcinoma: Results of the Mastectomy Reconstruction Outcomes Consortium Study

    • Colleen M. McCarthy
    • Jennifer B. Hamill
    • Andrea L. Pusic

    Breast Oncology 13 June 2017 Pages: 2502 - 2508

    

13. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ

    • Stephanie M. Wong
    • Tari King
    • Mehra Golshan

    Breast Oncology 28 April 2017 Pages: 2509 - 2517

14. Preoperative Prediction of Node-Negative Disease After Neoadjuvant Chemotherapy in Patients Presenting with Node-Negative or Node-Positive Breast Cancer

    • Brittany L. Murphy
    • Tanya L. Hoskin
    • Judy C. Boughey

    Breast Oncology 08 May 2017 Pages: 2518 - 2525

    

15. Trends in Sexual Function After Breast Cancer Surgery

    • Lauren F. Cornell
    • Dawn M. Mussallem
    • Sarah A. McLaughlin

    Breast Oncology 30 May 2017 Pages: 2526 - 2538

16. Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)

    • Peter Beitsch
    • Pat Whitworth
    • Laura A. Lee

    Breast Oncology 26 April 2017 Pages: 2539 - 2546

    

17. Cosmetic Outcome and Chronic Breast Toxicity After Intraoperative Radiation Therapy (IORT) as a Single Modality or as a Boost Using the Intrabeam^® Device: A Prospective Study

    • Stéphane Key
    • Petra Miglierini
    • Ulrike Schick

    Breast Oncology 12 June 2017 Pages: 2547 - 2555

    

18. Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant Chemotherapy

    • Oriana A. Petruolo
    • Melissa Pilewskie
    • Monica Morrow

    Breast Oncology 30 May 2017 Pages: 2556 - 2562

    

19. The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer

    • Faina Nakhlis
    • Meredith M. Regan
    • Beth Overmoyer

    Breast Oncology 30 May 2017 Pages: 2563 - 2569

    

20. Clinical Outcomes in pT4 Tongue Carcinoma are Worse than in pT3 Disease: How Extrinsic Muscle Invasion Should be Considered?

    • Chun-Ta Liao
    • Li-Yu Lee
    • Tzu-Chen Yen

    Head and Neck Oncology 03 June 2017 Pages: 2570 - 2579

    

21. Refining the Role of Lymph Node Biopsy in Survival for Patients with Nasopharyngeal Carcinoma: Population-Based Study from the Surveillance Epidemiology and End-Results Registry

    • Jia-Wei Lv
    • Guan-Qun Zhou
    • Ying Sun

    Head and Neck Oncology 05 July 2017 Pages: 2580 - 2587

    

22. Clinicopathological Determinants of an Elevated Systemic Inflammatory Response Following Elective Potentially Curative Resection for Colorectal Cancer

    • David G. Watt
    • Michelle L. Ramanathan
    • Donald C. McMillan

    Colorectal Cancer Open access 10 July 2017 Pages: 2588 - 2594

23. Total Laparoscopic Management for Stage IV Colorectal Cancer Requiring Multivisceral Resection

    • Y. Nancy You
    • Hironori Shiozaki
    • Claudius Conrad

    Colorectal Cancer 16 May 2017 Pages: 2595 - 2595

24. Lack of Efficacy of Radioiodine Remnant Ablation for Papillary Thyroid Microcarcinoma: Verification Using Inverse Probability of Treatment Weighting

    • Hyemi Kwon
    • Min Ji Jeon
    • Won Bae Kim

    Endocrine Tumors 09 June 2017 Pages: 2596 - 2602

    

25. Sporadic Small (≤20 mm) Nonfunctioning Pancreatic Neuroendocrine Neoplasm: is the Risk of Malignancy Negligible When Adopting a More Conservative Strategy? A Systematic Review and Meta-analysis

    • Claudio Ricci
    • Riccardo Casadei
    • Francesco Minni

    Endocrine Tumors 05 July 2017 Pages: 2603 - 2610

    

26. Disease Progression in Papillary Thyroid Cancer with Biochemical Incomplete Response to Initial Therapy

    • Nicole K. Zern
    • Roderick Clifton-Bligh
    • Mark Sywak

    Endocrine Tumors 05 June 2017 Pages: 2611 - 2616

    

27. Predictive Factors of Lymph Node Metastasis in Follicular Variant of Papillary Thyroid Carcinoma

    • Seo Ki Kim
    • Ah-Young Kwon
    • Jee Soo Kim

    Endocrine Tumors 06 July 2017 Pages: 2617 - 2623

    

28. Comparison of Long-Term Outcomes After Non-curative Endoscopic Resection in Older Patients with Early Gastric Cancer

    • Jeung Hui Pyo
    • Hyuk Lee
    • Sung Kim

    Gastrointestinal Oncology 17 May 2017 Pages: 2624 - 2631

    

29. Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study

    • C. Bisschop
    • T. H. van Dijk
    • G. A. P. Hospers

    Gastrointestinal Oncology Open access 30 May 2017 Pages: 2632 - 2638

    

30. Risk Factors for Poor Compliance with Adjuvant S-1 Chemotherapy for Gastric Cancer: A Multicenter Retrospective Study

    • Kotaro Yamashita
    • Yukinori Kurokawa
    • Yuichiro Doki

    Gastrointestinal Oncology 12 June 2017 Pages: 2639 - 2645

    

31. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection

    • Travis E. Grotz
    • Michael J. Overman
    • Keith F. Fournier

    Gastrointestinal Oncology 10 July 2017 Pages: 2646 - 2654

    

32. Prognostic Role of Primary Tumor Location in Non-Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis of 50 Studies

    • Fausto Petrelli
    • Michele Ghidini
    • Gianluca Tomasello

    Gastrointestinal Oncology 15 March 2017 Pages: 2655 - 2668

    

33. The Value of Multidisciplinary Team Meetings for Patients with Gastrointestinal Malignancies: A Systematic Review

    • Yara L. Basta
    • Sifra Bolle
    • Kristien M. A. J. Tytgat

    Gastrointestinal Oncology Open access 23 March 2017 Pages: 2669 - 2678

    

34. Patterns of Initial Recurrence in Gastric Adenocarcinoma in the Era of Preoperative Therapy

    • Naruhiko Ikoma
    • Hsiang-Chun Chen
    • Brian D. Badgwell

    Gastrointestinal Oncology 22 March 2017 Pages: 2679 - 2687

    

35. The Granulocyte-to-Lymphocyte Ratio as a Marker of Surgical Stress and a Predictor of Postoperative Infectious Complications After Gastric Cancer Surgery: An Analysis of Patients Enrolled in a Prospective Randomized Trial

    • Jun Lu
    • Hao Liu
    • Chang-ming Huang

    Gastrointestinal Oncology 29 March 2017 Pages: 2688 - 2697

    

36. Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma

    • Dagmar Kollmann
    • Desislava Ignatova
    • Sebastian F. Schoppmann

    Gastrointestinal Oncology Open access 20 April 2017 Pages: 2698 - 2706

    

37. Base Excess as a Predictor of Complications in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

    • Oliver S. Eng
    • Sinziana Dumitra
    • Byrne Lee

    Gastrointestinal Oncology 30 May 2017 Pages: 2707 - 2711

38. Adverse Effects of Low Preoperative Skeletal Muscle Mass in Patients Undergoing Gastrectomy for Gastric Cancer

    • Katsunobu Sakurai
    • Naoshi Kubo
    • Masaichi Ohira

    Gastrointestinal Oncology 05 May 2017 Pages: 2712 - 2719

    

39. Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study

    • Lucas Minig
    • Florian Heitz
    • Christina Fotopoulou

    Gynecologic Oncology 12 June 2017 Pages: 2720 - 2726

    

40. Radical Lymph Node Dissection Along the Proximal Splenic Artery During Laparoscopic Gastrectomy for Gastric Cancer Using the Left Lateral Approach

    • Shingo Kanaji
    • Satoshi Suzuki
    • Yoshihiro Kakeji

    Gastrointestinal Oncology 15 May 2017 Pages: 2727 - 2727

41. Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study

    • Georgia M. Beasley
    • Yinin Hu
    • Alicia M. Terando

    Melanomas 15 May 2017 Pages: 2728 - 2733

    

42. Induction Chemotherapy Followed by Resection or Irreversible Electroporation in Locally Advanced Pancreatic Cancer (IMPALA): A Prospective Cohort Study

    • Jantien A. Vogel
    • Steffi J. Rombouts
    • Marc G. Besselink

    Pancreatic Tumors 30 May 2017 Pages: 2734 - 2743

    

43. Analysis of Perioperative Chemotherapy in Resected Pancreatic Cancer: Identifying the Number and Sequence of Chemotherapy Cycles Needed to Optimize Survival

    • Irene Epelboym
    • Mazen S. Zenati
    • Amer H. Zureikat

    Pancreatic Tumors 05 July 2017 Pages: 2744 - 2751

    

44. Is Pancreatic Head Cancer with Portal Venous Involvement Really Borderline Resectable? Appraisal of an Upfront Surgery Series

    • Katsuhisa Ohgi
    • Yusuke Yamamoto
    • Katsuhiko Uesaka

    Pancreatic Tumors 06 July 2017 Pages: 2752 - 2761

    

45. CT Density in the Pancreas is a Promising Imaging Predictor for Pancreatic Ductal Adenocarcinoma

    • Yasunari Fukuda
    • Daisaku Yamada
    • Yuichiro Doki

    Pancreatic Tumors 20 June 2017 Pages: 2762 - 2769

    

46. Time to Initiation of Adjuvant Chemotherapy in Pancreas Cancer: A Multi-Institutional Experience

    • Brent T. Xia
    • Syed A. Ahmad
    • Daniel E. Abbott

    Pancreatic Tumors 09 June 2017 Pages: 2770 - 2776

    

47. A Prospective Phase II Trial of Neoadjuvant S-1 with Concurrent Hypofractionated Radiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma

    • Keiichi Okano
    • Hironobu Suto
    • Yasuyuki Suzuki

    Pancreatic Tumors 12 June 2017 Pages: 2777 - 2784

    

48. Completely Intracorporeal Handsewn Laparoscopic Anastomoses During Whipple Procedure

    • Giovanni Dapri
    • Nigel Antonio Bascombe
    • Sven Saussez

    Pancreatic Tumors 26 June 2017 Pages: 2785 - 2786

49. Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to Nephrectomy

    • Takuya Tsujino
    • Kazumasa Komura
    • Haruhito Azuma

    Urologic Oncology 22 June 2017 Pages: 2787 - 2793

    

50. Oncologic Outcome of Metastasectomy for Urothelial Carcinoma: Who Is the Best Candidate?

    • Tohru Nakagawa
    • Satoru Taguchi
    • Yukio Homma

    Urologic Oncology 07 July 2017 Pages: 2794 - 2800